The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
収録刊行物
-
- Nature Reviews Clinical Oncology
-
Nature Reviews Clinical Oncology 9 (10), 579-590, 2012-09-04
Springer Science and Business Media LLC